The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
In an increasingly complex global landscape, biotech and pharma companies face heightened risks in their supply chains due to natural disasters, geopolitical tensions, and regulatory changes. This whitepaper examines the evolution of these risks over the past 15 years and offers insights into proactive strategies for mitigating vulnerabilities in times of widespread volatility.
Drawing on industry trends and best practices, it provides valuable guidance on safeguarding supply chain integrity while seizing opportunities for improvement. It also explores how Thermo Fisher Scientific has developed a comprehensive strategy to manage and mitigate the impact of unexpected supply chain disruptions for its biotech and pharma customers.
Key insights include:
- How recent global events have exposed vulnerabilities in supply chains and sourcing strategies
- Key practices for strategic materials sourcing and supplier risk management to enhance resilience
- How to build and maintain strategic industry partnerships for long-term supply chain stability
- Practical steps to proactively monitor and mitigate risks in an unpredictable market environment
